832.102
KVVOAMAL
CH
Art. 34 Verordnung vom 27. Juni 1995 über die Krankenversicherung (KVV) - Analysen und Arzneimittel
KVV; 1. Teil: Obligatorische Krankenpflegeversicherung; 3. Titel: Leistungen; 1. Kapitel: Bezeichnung der Leistungen
Art. 34 KVV · Analysen und Arzneimittel
Die Listen nach Artikel 52 Absatz 1 Buchstabe a Ziffern 1 (Analysenliste) und 2 (Arzneimittelliste) sowie Buchstabe b (Spezialitätenliste) des Gesetzes werden nach Anhören der zuständigen Kommission erstellt.
Gerichtsentscheide zu dieser Bestimmung (4)
VSBES.2020.70 · so (Art. 34 und 64 ff. KVV)
Insured v. Health Insurer Regarding Coverage for Unlisted Compounded Hormone Therapy
Cited in the reasoning section regarding the exclusion of non-SL drugs from coverage.
A/4291/2017 · ge (art. 34 et 37e OAMal)
Insured v. Health Insurer re: Champix Coverage Limit
Cited in the reasoning section concerning the establishment of the list of specialties (LS).
KV.2013.12 · sg (Art. 52 Abs. 1 lit.a Ziff 1 KVG i.v.m. Art. 34 und Art. 37f KVV)
Insurer Coverage Obligation for Marfan Syndrome Genetic Testing Post-Aortic Surgery
The court's decision to order cost coverage implies that the analysis is covered under the positive list established based on these provisions, as discussed extensively in the reasoning regarding AL inclusion.
KV.2013.12 · sg (Art. 52 Abs. 1 lit.a Ziff 1 KVG i.v.m. Art. 34 und Art. 37f KVV)
Mandatory Health Insurance Coverage for Genetic Analysis in Marfan Syndrome Diagnosis
These provisions relate to the existence of the analysis list (AL) which was implicitly used to confirm that the analysis is generally included as a billed service, which supported the final order.